Curated News
By: NewsRamp Editorial Staff
June 26, 2024
NanoViricides Reports Promising Results for NV-387 in Influenza A H3N2 Mouse Model
Discuss on Reddit
Discuss on LinkedIn
Discuss on SubstackTLDR
- NV-387 provides significantly greater survival improvement compared to three approved influenza drugs, making it a powerful therapeutic option for treating severe influenza infections.
- NV-387 was found effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse model, resulting in lower immune system cell infiltration rates.
- NV-387 has the potential to address current and emerging viral threats, offering a critical development in the field of antiviral therapies, making it a better place.
- NV-387 oral treatment resulted in only about 31% lung infiltration by immune system cells, while intravenous treatment showed an even lower infiltration rate of about 22%.
Impact - Why it Matters
This news highlights the potential of NV-387 as a powerful therapeutic option for treating severe influenza infections and possibly other respiratory viral infections. It is a critical development in the field of antiviral therapies, especially in addressing both current and emerging viral threats.
Summary
NanoViricides CEO Dr Anil Diwan shared promising news about the company's ultra-broad-spectrum antiviral, NV-387. The antiviral was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse model. NV-387 significantly protects the lungs of Balb/c mice lethally infected with the Influenza A H3N2 virus and resulted in a significantly greater survival improvement compared to three approved influenza drugs. These findings highlight the potential of NV-387 as a powerful therapeutic option for treating severe influenza infections and possibly other respiratory viral infections. This is a critical development in the field of antiviral therapies, especially in addressing both current and emerging viral threats.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, NanoViricides Reports Promising Results for NV-387 in Influenza A H3N2 Mouse Model
